友情提示:以下期刊信息可能会有更新,仅供参考,请在投稿前自行登录期刊官网仔细核实。
期刊名
Pharmacogenetics and Genomics
PHARMACOGENET GENOM
ISSN / eISSN
1744-6872 / 1744-6880
目标和范围
Pharmacogenetics and Genomics is devoted to the rapid publication of research papers, brief review articles and short communications on genetic determinants in response to drugs and other chemicals in humans and animals. The Journal brings together papers from the entire spectrum of biomedical research and science, including biochemistry, bioinformatics, clinical pharmacology, clinical pharmacy, epidemiology, genetics, genomics, molecular biology, pharmacology, pharmaceutical sciences, and toxicology. Under a single cover, the Journal provides a forum for all aspects of the genetics and genomics of host response to exogenous chemicals: from the gene to the clinic.
研究方向
生物工程与应用微生物
遗传学
药学
CiteScore
3.20
查看趋势图
CiteScore 学科排名
类别 | 分区 | 排名 |
---|---|---|
Pharmacology, Toxicology and Pharmaceutics - General Pharmacology, Toxicology and Pharmaceutics | Q2 | #27/80 |
Pharmacology, Toxicology and Pharmaceutics - Genetics (clinical) | Q3 | #66/99 |
Pharmacology, Toxicology and Pharmaceutics - Genetics | Q3 | #250/347 |
Pharmacology, Toxicology and Pharmaceutics - Molecular Medicine | Q4 | #137/178 |
Pharmacology, Toxicology and Pharmaceutics - Molecular Biology | Q4 | #319/410 |
Web of Science 核心收藏夹
Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
---|---|
Indexed | - |
类别 (Journal Citation Reports 2024) | 分区 |
---|---|
BIOTECHNOLOGY & APPLIED MICROBIOLOGY | Q4 |
GENETICS & HEREDITY | Q3 |
PHARMACOLOGY & PHARMACY | Q3 |
H-index
134
出版国家或地区
UNITED STATES
出版商
Lippincott Williams and Wilkins Ltd.
出版周期
Monthly
出版年份
2005
年文章数
23
Open Access
NO
通讯方式
LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now